Pursuant to applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that it enclosed Corrigendum to the Notice for the Annual General Meeting scheduled to be held on Tuesday, 21 July 2026 at 10:30 am (IST) through Video Conference / Other Audio-Visual Means. Post-dispatch of the notice, it has come to the attention of the Company that due to an inadvertent typographical/ clerical error, one of the remuneration terms appearing in the Explanatory Statement to the resolution set out at Item No. 6 of the AGM Notice, relating to the re-appointment of the Executive Director of the Company, was incorrectly mentioned on page no. 17 of the AGM Notice. Accordingly, the company has informed that the gross salary shall be read as INR 10 lakh per month instead of INR 8.40 lakh per month, as mentioned in the Explanatory Statement. The said correction is only to rectify the inadvertent typographical / clerical error and is in line with the remuneration terms approved by the Board of Directors while considering the re-appointment of the Executive Director. This Corrigendum shall form an integral part of and should be read in conjunction with the Notice of the 39th Annual General Meeting. In view of the aforesaid, the inadvertent mistake is now rectified and the notice with the updated explanatory statement is attached.
The above information is a part of company’s filings submitted to BSE.
